Technology augmented investing

Lazarus Goh

Augmenting fundamental investing with technology

Open Diligence

We aim to a) increase the efficacy of investment processes with technology and b) utilize alternative data to gain an additional perspective on equity names

Companies are most happy to announce new partnerships with potential customers or established firms that bolster credibility to their business and/or technology.However, when such partnerships dissolve, some companies do not disclose the fact - they simply remove mentions of these partnerships in their disclosures. It is from these omissions that we discover potential dissolving of partnerships.In the past weeks, two small-cap firms showed signs of such tendency.

Companies are most happy to announce new partnerships with potential customers or established firms that bolster credibility to their business and/or technology.However, when such partnerships dissolve, some companies do not disclose the fact - they simply remove mentions of these partnerships in their disclosures. It is from these omissions that we discover potential dissolving of partnerships.In the past weeks, two small-cap firms showed signs of such tendency.

Dissolved Partnerships that Remain Undisclosed (January Screener)

United States

Anixa Biosciences, Inc. operates as a bio-technology company. The Company develops diagnostics and therapeutics to detect cancer. Anixa Biosciences serves clients in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Anixa Biosciences Inc (ANIX US)

Dissolved Partnerships that Remain Undisclosed (January Screener)

Two US-listed companies omitted the mention of key partners/customers in their recent annual report, suggesting that these partnerships have been...

Lazarus Goh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)